Skip to content
10-Q

Quarterly Report

BIOFORCE NANOSCIENCES HOLDINGS, INC. BFNH

0001091818-25-000163

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 17, 2025 33.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.1M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 29.27M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$54.23K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$46.42K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $784
Cash And Equivalents Q3 2025 · Dec 31, 2024 $862
Stockholders Equity Q3 2025 · Sep 30, 2025 −$499.94K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$384.02K
Stockholders Equity Q3 2025 · Mar 31, 2025 −$261.24K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$2.3M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$2.18M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$2.06M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$1.95M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$1.82M
Current Liabilities Q3 2025 · Sep 30, 2025 $500.72K
Current Liabilities Q3 2025 · Dec 31, 2024 $2.3M
Total Liabilities Q3 2025 · Sep 30, 2025 $500.72K
Total Liabilities Q3 2025 · Dec 31, 2024 $2.3M
Current Assets Q3 2025 · Sep 30, 2025 $784
Current Assets Q3 2025 · Dec 31, 2024 $862
Total Assets Q3 2025 · Sep 30, 2025 $784
Total Assets Q3 2025 · Dec 31, 2024 $862
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 $0.00
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Sga Expense Q3 2025 · Sep 30, 2025 $10.17K
Sga Expense Q3 2025 · Sep 30, 2025 $54.9K
Sga Expense Q3 2025 · Sep 30, 2024 $16.27K
Sga Expense Q3 2025 · Sep 30, 2024 $50.03K
Net Income Q3 2025 · Sep 30, 2025 −$115.92K
Net Income Q3 2025 · Sep 30, 2025 −$1.17M
Net Income Q3 2025 · Sep 30, 2024 −$122.02K
Net Income Q3 2025 · Sep 30, 2024 −$367.28K
Operating Income Q3 2025 · Sep 30, 2025 −$115.92K
Operating Income Q3 2025 · Sep 30, 2025 −$372.15K
Operating Income Q3 2025 · Sep 30, 2024 −$122.02K
Operating Income Q3 2025 · Sep 30, 2024 −$367.28K